Technology: Atrificial Vectors and Immune Cells
Industry: Atrificial Vectors and Immune Cells
Headquarters: San Francisco, California, United States
Founded Date: 2015-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 13
Total Funding: 5348629
Estimated Revenue: $10M to $50M
Last Funding Date: 2022-07-05
Last Funding Type: Post-IPO Equity

Visit Website
info@codiakbio.com
Register and Claim Ownership